Sign inJoin waitlistJoin the waitlist

Hung Khong

Key Faculty · University of Arizona College of Medicine - Phoenix

Credentials: · · · · · ·

History

University of Arizona College of Medicine - Phoenix
Present

National Cancer Institute
1997–1999
Baylor College of Medicine
1994–1997
Temple University School of Medicine
1990–1994

Research

Natural selection of tumor variants in the generation of "tumor escape" phenotypes
Review · Nature Immunology · 2002 · First of 2 authors · Corresponding · 828 citations
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced…
Journal of Clinical Oncology · 2022 · 629 citations
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
Review · Trends in Immunology · 2005 · 374 citations

Steven Rosenberg
8 papers
Brian Czerniecki
6 papers
HS
Hatem Soliman
6 papers
HH
Hyo Han
6 papers
RC
Ricardo Costa
6 papers
AS
Aixa Soyano
5 papers
Douglas Grossman
5 papers
GB
Glen Bowen
5 papers
KG
Kenneth Grossmann
5 papers
RA
Robert Andtbacka
5 papers
Tawnya Bowles
5 papers
AA
Avan Armaghani
4 papers

Clinical trials

Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
Principal investigator · Terminated · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
2019–2021
A Study of Intratumoral Injection of Interleukin-2 and Ipilimumab in Patients With Unresectable Stages III-IV Melanoma
Principal investigator · Completed · Phase 1
University of Utah
2012–2014
Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast Cancer
Principal investigator · Terminated · Phase 1
University of Utah
2008–2017
A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer
Principal investigator · Completed · Phase 1, Phase 2
University of Utah
2008–2015